Acadia Pharmaceuticals | Betriebsergebnis



Operating Profit Veränderung Datum
Acadia Pharmaceuticals USD 19.29M 134.21M 2025-03
ALKERMES USD 13.79M 148.9M 2025-03
Alnylam Pharmaceuticals USD 18.08M 123.24M 2025-03
Biogen USD 311.2M 130.2M 2025-03
BioMarin Pharmaceutical USD 223.89M 62.49M 2025-03
Bristol-Myers Squibb USD 3.41B 2.62B 2025-03
Corcept Therapeutics USD 3.42M 21.85M 2025-03
Cytokinetics USD -155631000 16.59M 2025-03
Eisai JPY -1024000000 28.59B 2025-03
Eli Lilly USD 5.41B 259.6M 2025-03
Incyte USD 205.17M 96.34M 2025-03
J&J USD 13.63B 9.74B 2025-03
Moderna USD -1050000000 196M 2025-03
Neurocrine Biosciences USD 142M 41.8M 2024-12
Pfizer USD 3.67B 4.08B 2025-03
Prothena USD -64897000 1.62M 2024-12
PTC Therapeutics USD 970.22M 1.03B 2025-03
Sarepta Therapeutics USD -300386000 462.07M 2025-03
Ultragenyx Pharmaceutical USD -142939000 20.66M 2025-03
Vertex Pharmaceuticals USD 1.03B 90.3M 2024-12



Acadia Pharmaceuticals Betriebsergebnis - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - May 2025.